menu
    • menu

    Company profile for KALA Bio

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kala Bio is a clinical-stage biopharmaceutical company dedicated to tackling rare and serious eye diseases through innovative therapy development. A leader in the emerging field of mesenchymal stem cell secretome (MSC-S) therapy, Kala Bio utilizes its proprietary MSC-S platform to create therapies that promote regenerative healing effects for rare ocular surface and retinal diseases. The company's mission is centered around pr...
    Kala Bio is a clinical-stage biopharmaceutical company dedicated to tackling rare and serious eye diseases through innovative therapy development. A leader in the emerging field of mesenchymal stem cell secretome (MSC-S) therapy, Kala Bio utilizes its proprietary MSC-S platform to create therapies that promote regenerative healing effects for rare ocular surface and retinal diseases. The company's mission is centered around preserving vision and improving quality of life for patients, with a strong commitment to advancing therapeutic options in ophthalmology through cutting-edge research and development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KALA BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1167 Massachusetts Avenue, Arlington, MA 02476
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kalarx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kala-bio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KALA BIO Launches Cutting-Edge AI System: Bionic Intelligence
    KALA BIO Launches Cutting-Edge AI System: Bionic Intelligence

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264632/0/en/KALA-BIO-Delivers-Industry-Leading-AI-Infrastructure-Bionic-Intelligence-Research-Agent-Now-Live.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Red Light Holland Utilizes Kala Bio's Researgency.Ai For PEX010
    Red Light Holland Utilizes Kala Bio's Researgency.Ai For PEX010

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258234/0/en/Red-Light-Holland-Engages-Kala-Bio-s-Researgency-AI-Platform-to-Support-Clinical-Development-of-Filament-s-Patented-PEX010-Botanical-Psilocybin-Drug-Candidate.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Kala Bio Sparks $180B Biotech Boom in Just 14 Days
    Kala Bio Sparks $180B Biotech Boom in Just 14 Days

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253600/0/en/Kala-Bio-Launches-a-Revolution-for-Biotech-First-AI-Agent-Deploying-in-14-Days-as-180-Billion-Agentic-AI-Healthcare-Revolution-Accelerates.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Kala Bio Unveils Researgency AI, Inks Key Deal
    Kala Bio Unveils Researgency AI, Inks Key Deal

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249169/0/en/KALA-BIO-Announces-Strategic-Initiative-to-Deploy-and-Continue-to-Develop-an-On-Premises-AI-Infrastructure-Platform-for-the-Biotech-Industry-Enters-Into-Platform-Development-and-Ex.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    KALA BIO Settles Approximately $10.6 Million Of Debt
    KALA BIO Settles Approximately $10.6 Million Of Debt

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3213204/0/en/KALA-BIO-Settles-Approximately-10-6-million-of-Debt.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    KALA BIO Closes $10M Common Stock Offering Under Nasdaq Rules
    KALA BIO Closes $10M Common Stock Offering Under Nasdaq Rules

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200949/0/en/KALA-BIO-Announces-Closing-of-10-Million-Registered-Direct-Offering-of-Common-Stock-Priced-At-The-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search